GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for tyrosine 2,3-aminomutase (B8ZV94)

Analyse AlphaFold monomer V2.0 prediction for tyrosine 2,3-aminomutase (B8ZV94) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B8ZV94
Type
protein
Length
526 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x5c4adF1416281C09AE8eE1cbb80fF7e44cE86F97
Molecule
Tyrosine 2,3-aminomutase
UniProt
B8ZV94
Pockets
4 · best druggability 0.55

Structure

1 distinct chain · 58% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine 2,3-aminomutaseprotein52658% helix, 5% strandB8ZV94

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11810.550.8028empty
2690.490.8415empty
31160.450.7830empty
4820.340.7515empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.